Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of clinical data to show that the drug is less likely to be abused.

Tris Pharma has set its sights on an FDA filing for pipeline drug cebranopadol before the end of this year after the drug achieved significant pain relief in abdominoplasty patients in a late ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ALLEVIATE-1 pivotal Phase 3 ...

Simmons took over the 24 Waterway Ave. space, previously the combination grocery store-restaurant Hubbel & Hudson, in 2018. Under his tenure, Tris' menu garnered critical acclaim for its modern ...

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. The company tested cebranopadol, a dual nociceptin ...

Bestselling author Veronica Roth, the creator of the Divergent franchise, reflects on the book series' most divisive ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got lots of news coming out of D.C. today ...

Phase 3 trial shows promising pain relief for acute pain patients Tris Pharma, Inc. has announced positive results from its ALLEVIATE-1 phase 3 clinical trial evaluating cebranopadol for treating ...

Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate-to-severe acute pain in individuals post-abdominoplasty surgery.

All the Latest Game Footage and Images from Alchemist Tris's Desire Control the main character, Alchemist Tris. and collect the materials for the items needed to solve the problems of the villagers.